BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35034789)

  • 1. No Influence of Everolimus on Mycophenolic Acid Area Under the Concentration-Time Curve: Limited Sampling Strategy for Mycophenolic Acid in Japanese Kidney Transplant Recipients Treated With Tacrolimus, Mycophenolate Mofetil, Steroid, and Everolimus.
    Endo T; Ishimura T; Nishioka S; Yokoyama N; Ogawa S; Fujisawa M
    Transplant Proc; 2022 Mar; 54(2):286-292. PubMed ID: 35034789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    J Clin Pharmacol; 2003 Aug; 43(8):866-80. PubMed ID: 12953344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited Sampling Strategy for the Estimation of Mycophenolic Acid and its Acyl Glucuronide Metabolite Area under the Concentration-Time Curve in Japanese Lung Transplant Recipients.
    Tanaka M; Kikuchi M; Takasaki S; Hirasawa T; Sigeta K; Noda A; Akiba M; Matsuda Y; Oishi H; Sado T; Noda M; Okada Y; Mano N; Yamaguchi H
    J Pharm Pharm Sci; 2019; 22(1):407-417. PubMed ID: 31430249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited sampling strategy for simultaneous estimation of the area under the concentration-time curve of tacrolimus and mycophenolic acid in adult renal transplant recipients.
    Miura M; Satoh S; Niioka T; Kagaya H; Saito M; Hayakari M; Habuchi T; Suzuki T
    Ther Drug Monit; 2008 Feb; 30(1):52-9. PubMed ID: 18223463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
    Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Witzke O; Hugo C; Kamar N; Merville P; Junge M; Thaiss F; Nashan B;
    Kidney Int; 2019 Jul; 96(1):231-244. PubMed ID: 31027892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited Sampling Strategy for Estimation of Mycophenolic Acid Exposure in Adult Chinese Heart Transplant Recipients.
    Xiang H; Zhou H; Zhang J; Sun Y; Wang Y; Han Y; Cai J
    Front Pharmacol; 2021; 12():652333. PubMed ID: 33912061
    [No Abstract]   [Full Text] [Related]  

  • 7. Defining algorithms for efficient therapeutic drug monitoring of mycophenolate mofetil in heart transplant recipients.
    Kaczmarek I; Bigdeli AK; Vogeser M; Mueller T; Beiras-Fernandez A; Kaczmarek P; Schmoeckel M; Meiser B; Reichart B; Ueberfuhr P
    Ther Drug Monit; 2008 Aug; 30(4):419-27. PubMed ID: 18641552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in Tunisian renal transplant patients.
    Gaies E; Ben Sassi M; El Jebari H; Jebabli N; Charfi R; Chokri I; Salouage I; Klouz A; Trabelsi S
    Nephrol Ther; 2017 Nov; 13(6):460-462. PubMed ID: 28958670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited Sampling Strategy for Mycophenolic Acid in Chinese Kidney Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus During the Early Posttransplantation Phase.
    Yao X; Huang H; Wei C; Chen Y; Peng W; Xie W; Chen J
    Ther Drug Monit; 2015 Aug; 37(4):516-23. PubMed ID: 25565669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.
    Mardigyan V; Giannetti N; Cecere R; Besner JG; Cantarovich M
    J Heart Lung Transplant; 2005 Oct; 24(10):1614-8. PubMed ID: 16210138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited sampling strategy for the estimation of mycophenolic acid area under the concentration-time curve treated in Japanese living-related renal transplant recipients with concomitant extended-release tacrolimus.
    Yamaguchi K; Fukuoka N; Kimura S; Watanabe M; Tani K; Tanaka H; Sofue T; Kosaka S; Inui M; Kakehi Y; Houchi H
    Biol Pharm Bull; 2013; 36(6):1036-9. PubMed ID: 23558676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and Validation of a Limited Sampling Strategy to Monitor Mycophenolic Acid Exposure in Children With Nephrotic Syndrome.
    Benz MR; Ehren R; Kleinert D; Müller C; Gellermann J; Fehrenbach H; Schmidt H; Weber LT
    Ther Drug Monit; 2019 Dec; 41(6):696-702. PubMed ID: 31425441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective and Safe Reduction of Conventional Immunosuppressants Using Everolimus in Maintenance Kidney Transplant Recipients.
    Nanmoku K; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Yagisawa T
    Transplant Proc; 2017 Oct; 49(8):1724-1728. PubMed ID: 28923615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid Area Under the Concentration-Time Curve Estimation.
    Sobiak J; Resztak M
    Eur J Drug Metab Pharmacokinet; 2021 Nov; 46(6):721-742. PubMed ID: 34480746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited sampling strategy for predicting area under the concentration-time curve for mycophenolic Acid in Chinese adults receiving mycophenolate mofetil and tacrolimus early after renal transplantation.
    Cai W; Ye C; Sun X; Qin K; Qin Y; Zhao D; Wu F; Hu Y; Li H; Tan L
    Ther Drug Monit; 2015 Jun; 37(3):304-10. PubMed ID: 25525761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited sampling strategy to predict free mycophenolic acid area under the concentration-time curve in paediatric patients with nephrotic syndrome.
    Sobiak J; Żero P; Zachwieja J; Ostalska-Nowicka D; Pawiński T
    Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):486-496. PubMed ID: 36846865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy.
    Filler G
    Transpl Int; 2004 Mar; 17(3):120-5. PubMed ID: 14749919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients.
    Cai W; Cai Q; Xiong N; Qin Y; Lai L; Sun X; Hu Y
    Transplant Proc; 2018 Jun; 50(5):1298-1304. PubMed ID: 29735215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.